Press Releases

Dr. Peter L. Levin, Blue Button Healthcare Innovator, Joins USAgainstAlzheimer's Network

October 28, 2013

Dr. Peter L. Levin, Blue Button Healthcare Innovator, Joins USAgainstAlzheimer's Network

USAgainstAlzheimer’s Network Strengthens Innovation Capacity in Race to Stop Alzheimer’s by 2025

WASHINGTON, D.C. – The USAgainstAlzheimer's Network today announced that Dr. Peter L. Levin, developer of Blue Button personal health record technology during his role as Chief Technology Officer for the U.S. Department of Veteran Affairs, will join the USAgainstAlzheimer’s Network’s Board.

Jeff Eller, Communications Strategist, Joins USAgainstAlzheimer's Board

October 28, 2013

Jeff Eller, Communications Strategist, Joins USAgainstAlzheimer's Board

USAgainstAlzheimer’s Strengthens Role in Advancing Alzheimer’s Solutions

WASHINGTON, D.C. – USAgainstAlzheimer's today announced that Jeff Eller, chairman of Public Strategies, Inc. and former Deputy Assistant to the President and Director of Media Affairs in the Clinton Administration, will join USAgainstAlzheimer’s Board.

USAgainstAlzheimer’s Disappointed with Decision Limiting Innovative Diagnostic Tool Coverage

October 1, 2013

USAgainstAlzheimer’s Disappointed with Medicare’s Final Decision To Limit Coverage of Innovative Diagnostic Tool

Despite public protest, decision will bar thousands of Alzheimer’s and dementia patients from access to PET beta-amyloid scans that help optimize diagnoses

AFRICAN AMERICANS BEAR MORE THAN ONE-THIRD OF U.S. ALZHEIMER’S COSTS

September 19, 2013

AFRICAN AMERICANS BEAR MORE THAN ONE-THIRD OF U.S. ALZHEIMER’S COSTS

AfricanAmericanNetworkAgainstAlzheimer’s Launches with New Report on Alzheimer’s Disparities

African American Network Against Alzheimer’s to Partner with Award Winning Playwright Garrett Davis

August 29, 2013

African American Network Against Alzheimer’s to Partner with Award Winning Playwright Garrett Davis

Davis, Founder of the Forget Me Not Project, Brings Innovative Approach to Advocacy in Effort to Fulfill Network’s Mission to End Alzheimer’s by 2020

Why 2020?

USAgainstAlzheimer’s has retained its goal of stopping Alzheimer’s by 2020 rather than endorsing the goal of the National Plan to Address Alzheimer’s Disease that calls for preventing and effectively treating the disease by 2025. While we support the national plan and its goals, we believe, as most every family touched by Alzheimer’s disease believes, that preventing and effectively treating Alzheimer's by 2025 is simply too long a wait for concrete progress. There are promising avenues of drug discovery and development that will, if successful, deliver a means of slowing or deferring Alzheimer's symptoms by 2020. By voicing the urgency felt by so many families, we will pressure researchers and industry to do all in their power to make that happen.